← Back to the Areas of Interest
MSD - Evolving treatment paradigms for head and neck squamous cell carcinoma (HNSCC)
View the full invitation
Merck - The dynamic map of treatment for SCCHN: The optimal pathway for your patient (Commercial)
Programme and Faculty are preliminary and subject to change.
© 2019 cSLIDE CTI MEETING TECHNOLOGY. All rights reserved.